Repligen Balance Sheet Health
Financial Health criteria checks 5/6
Repligen has a total shareholder equity of $2.0B and total debt of $521.6M, which brings its debt-to-equity ratio to 25.9%. Its total assets and total liabilities are $2.8B and $814.0M respectively. Repligen's EBIT is $25.7M making its interest coverage ratio -2.9. It has cash and short-term investments of $784.0M.
Key information
25.9%
Debt to equity ratio
US$521.61m
Debt
| Interest coverage ratio | -2.9x |
| Cash | US$783.96m |
| Equity | US$2.02b |
| Total liabilities | US$813.96m |
| Total assets | US$2.83b |
Recent financial health updates
Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08
We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15Recent updates
Repligen Corporation's Earnings Preview: Expensive With Mixed Growth Prospects
Nov 12Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08Is It Time To Consider Buying Repligen Corporation (NASDAQ:RGEN)?
Oct 14Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 28% Above Its Share Price
Sep 08Repligen Corporation (NASDAQ:RGEN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 31We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen: Strong Filtration Growth, Offset By Other Challenges
Jul 13Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge
Jun 14Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?
Jun 10Repligen Stock: Still Quite Overvalued
May 30Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models
May 03Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Apr 30Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?
Feb 13Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Jan 08Financial Position Analysis
Short Term Liabilities: RGEN's short term assets ($1.1B) exceed its short term liabilities ($108.4M).
Long Term Liabilities: RGEN's short term assets ($1.1B) exceed its long term liabilities ($705.6M).
Debt to Equity History and Analysis
Debt Level: RGEN has more cash than its total debt.
Reducing Debt: RGEN's debt to equity ratio has increased from 22% to 25.9% over the past 5 years.
Debt Coverage: RGEN's debt is well covered by operating cash flow (31.7%).
Interest Coverage: RGEN earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 08:21 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Repligen Corporation is covered by 26 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Wasserman | Benchmark Company |
| Hugo Solvet | BNP Paribas Exane |
| Kyle Mikson | Canaccord Genuity |